Answers are grounded in this paper and cite their sources.
Sepsis is a life-threatening syndrome driven by dysregulated inflammation, excessive oxidative stress, and progressive organ injury, yet therapies that concurrently control these interconnected processes remain limited. Restoring redox homeostasis while suppressing NF-κB-mediated inflammatory activation and correcting macrophage dysfunction therefore represents a key therapeutic objective. However, conventional antioxidant and anti-inflammatory agents are often constrained by limited stability, bioavailability, nonspecific distribution, and insufficient coordination of redox and immune regulation. Here, cerium-quercetin nanoparticles (CQ NPs) were prepared by combining cerium species with quercetin. CQ NPs exhibited concentration-dependent scavenging of ·OH and O 2 · − , reduced intracellular ROS level and apoptosis, preserved mitochondrial membrane potential, increased Nrf2 and HO-1 expression, decreased p-p65/p65 and p-IκBα/IκBα ratios, and altered CD86/CD206 expression. In mice with CLP-induced sepsis, CQ NPs reduced circulating TNF-α, IL-6, and IL-1β, attenuated pulmonary histopathological injury, and were associated with improved survival. These findings suggest that CQ NPs exhibit antioxidant and inflammation-associated effects in experimental sepsis, warranting further investigation into their underlying mechanisms and therapeutic potential.
No takes yet. Share an insight, caveat, or question.
宋刘广 et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: